The odds ratio of the hypoglycemic incidence rate was 1.02 (95% CI: 0.74 to 1.42, 4596 patients from 11 studies), indicating that adding a DPP-4 inhibitor did not significantly increase the incidence of hypoglycemia. This evidence concerns the gene DPP4 and Hypoglycemia.